Using a 5-year unlevered FCFF model with Gordon Growth terminal value, Boston Scientific Corporation (BSX) has an intrinsic value of $36.33 (range: $20.76 – $100.03), suggesting the stock is overvalued by 48.7% relative to its current market price of $70.88.
Sweet Value Lab's quantitative models and Wall Street analysts diverge on Boston Scientific Corporation (BSX). Our models suggest the stock is overvalued by 49%, while analysts see 53% upside. This gap may reflect growth expectations not yet visible in current financials.
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions. Data sourced from SEC filings via Financial Modeling Prep. Last updated: 3/28/2026.